FAQ on Keystone's Formation of Gillson Sciences

What is Gillson Sciences?

Gillson Sciences is a provider of laboratory testing, monitoring, and advisory solutions aimed at delivering quality, compliance, and regulatory excellence to clients in pharmaceuticals, biopharma, medical devices, healthcare, and environmental sciences.

Why was Gillson Sciences formed?

Gillson Sciences was formed to offer science-driven support to clients for developing, sourcing, manufacturing, and commercializing safe and effective products, addressing a broad range of human health challenges.

How was Gillson Sciences established?

Gillson Sciences was established in January 2025 through the acquisitions of Azzur Labs and Micro Measurement Laboratories, combining their expertise to provide comprehensive, integrated scientific solutions.

Who is leading Gillson Sciences?

Jason Fischer, with a background at UL Solutions, serves as the CEO of Gillson Sciences, overseeing its strategy and management to build a market leader in testing, monitoring, and advisory solutions.

Where is Gillson Sciences based and where does it operate?

Gillson Sciences is based in Chicago, Illinois, and operates laboratories in Pennsylvania, Illinois, and California, with field personnel across the U.S.

What are the future plans for Gillson Sciences?

Gillson Sciences plans to expand its capabilities and reach within the testing, inspection, certification, and compliance sector, partnering with organizations that share its mission of advancing quality and safety.

Who provided legal counsel for the formation of Gillson Sciences?

Dentons LLP provided legal counsel for the formation of Gillson Sciences, although the terms of the transaction were not disclosed.

What is Keystone Capital’s role in Gillson Sciences?

Keystone Capital Management partnered with Jason Fischer to form Gillson Sciences, investing in the company to build long-term value through organic growth and strategic acquisitions.